PMID- 38090319 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20231213 IS - 2072-1439 (Print) IS - 2077-6624 (Electronic) IS - 2072-1439 (Linking) VI - 15 IP - 11 DP - 2023 Nov 30 TI - A signature of five 7-methylguanosine-related genes is a prognostic marker for lung squamous cell carcinoma. PG - 6265-6278 LID - 10.21037/jtd-23-1504 [doi] AB - BACKGROUND: N(7)-methylguanosine (m7G) is an important posttranscriptional modification affecting mRNA and tRNA functions and stability. The genes regulating the m7G process have been previously found involved in the carcinogenesis process. We aimed to analyze the role of m7G-related genes as potential prognostic markers for lung squamous cell carcinoma (LSCC). METHODS: Twenty-nine m7G-related genes were selected for the analysis in the LSCC cohort of the Cancer Genome Atlas (TCGA). Univariate, multivariate, and Kaplan-Meier analyses were used to evaluate the predictive value of risk model developed with m7G signature for overall survival (OS).. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of differentially expressed genes (DEGs) were performed for high- and low-risk LSCC groups. RESULTS: We identified 17 differentially expressed m7G methylation-related genes in LSCC versus normal tissues. The expression of five m7G-related genes (EIF3D, LSM1, NCBP2, NUDT10, and NUDT11) was identified as an independent prognostic marker for OS in LSCC patients. A risk model with these five m7G-related genes predicted 2-, and 3-year survival rates of 0.623 and 0.626, respectively. The risk score significantly correlated with OS: LSCC patients with a higher risk score had shorter OS (P<0.01) and it was associated with lower immune response (P<0.01). CONCLUSIONS: We developed a novel m7G-related gene signature that can be of great utility to predict the prognosis for patients with LSCC. CI - 2023 Journal of Thoracic Disease. All rights reserved. FAU - Liu, Wensheng AU - Liu W AD - Critical Care Medicine Department, Zhejiang Cancer Hospital, Hangzhou, China. FAU - Wang, Ying AU - Wang Y AD - Gynecological Oncology Department, Zhejiang Cancer Hospital, Hangzhou, China. FAU - Ulivi, Paola AU - Ulivi P AD - Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" (IRST), Meldola, Italy. FAU - Tavolari, Simona AU - Tavolari S AD - Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. FAU - Rizvi, Syed A A AU - Rizvi SAA AD - College of Biomedical Sciences, Larkin University, Miami, FL, USA. FAU - Capobianco, Enrico AU - Capobianco E AD - Department of Computational Science, The Jackson Laboratory, Farmington, CT, USA. FAU - Navarro, Alfons AU - Navarro A AD - Molecular Oncology and Embryology Laboratory, Department of Surgery and Surgical Specializations, Human Anatomy Unit, Faculty of Medicine and Health Sciences, University of Barcelona (UB), Barcelona, Spain. FAU - Zhang, Yongjun AU - Zhang Y AD - Integration of Traditional Chinese and Western Medicine Department, Zhejiang Cancer Hospital, Hangzhou, China. LA - eng PT - Journal Article DEP - 20231127 PL - China TA - J Thorac Dis JT - Journal of thoracic disease JID - 101533916 PMC - PMC10713324 OTO - NOTNLM OT - N7-methylguanosine (m7G) OT - Non-small cell lung cancer (NSCLC) OT - The Cancer Genome Atlas (TCGA) OT - biomarker OT - prognosis COIS- Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1504/coif). The authors have no conflicts of interest to declare. EDAT- 2023/12/13 18:42 MHDA- 2023/12/13 18:43 PMCR- 2023/11/30 CRDT- 2023/12/13 13:07 PHST- 2023/09/26 00:00 [received] PHST- 2023/11/09 00:00 [accepted] PHST- 2023/12/13 18:43 [medline] PHST- 2023/12/13 18:42 [pubmed] PHST- 2023/12/13 13:07 [entrez] PHST- 2023/11/30 00:00 [pmc-release] AID - jtd-15-11-6265 [pii] AID - 10.21037/jtd-23-1504 [doi] PST - ppublish SO - J Thorac Dis. 2023 Nov 30;15(11):6265-6278. doi: 10.21037/jtd-23-1504. Epub 2023 Nov 27.